Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 2 diabetes
Pharma
Lilly touts winning tirzepatide data in prediabetes patients
Lilly on Wednesday laid out full results from its longest completed study of the dual GIP/GLP-1 receptor agonist tirzepatide to date.
Fraiser Kansteiner
Nov 13, 2024 5:01pm
FDA expert panel spurns Lexicon's approval bid in type 1 diabetes
Nov 1, 2024 11:24am
NHS England proposes phased rollout for Lilly's obesity med
Oct 3, 2024 3:22pm
Dexcom picks 'Parks & Rec' star to launch Glucose Awareness Week
Sep 23, 2024 10:37am
Novo won't file for IcoSema approval in US
Aug 13, 2024 1:40pm
Novo Nordisk's once-weekly insulin gets a thumbs-down from FDA
Jul 11, 2024 10:05am
